Track topics on Twitter Track topics that are important to you
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”) will release its third quarter 2018 operational and financial results after market hours on November 12, 20...
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”) will release its 2018 fourth quarter and year end operational and financial results after market hours on M...
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”) today announced its third quarter 2018 operational and financial results. For more information, please refe...
Operating through 47 Company-operated treatment centers, Greenbrook is a leading provider of Transcranial Magnetic Stimulation (TMS), an FDA-cleared, non-invasive therapy for the ...
We have published hundreds of Greenbrook TMS Inc. news stories on BioPortfolio along with dozens of Greenbrook TMS Inc. Clinical Trials and PubMed Articles about Greenbrook TMS Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Greenbrook TMS Inc. Companies in our database. You can also find out about relevant Greenbrook TMS Inc. Drugs and Medications on this site too.
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...
Psychiatry is the study of mental disorders and their diagnosis, management and prevention. Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...